siRNA therapeutics for CNS disorders (Sylentis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamesiRNA therapeutics for CNS disorders (Sylentis)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCNS modulators
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSylentis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSylentis Sa
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A